CYP2A7
Basic information
Region (hg38): 19:40875439-40882752
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP2A7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 67 | 77 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 67 | 4 | 8 |
Variants in CYP2A7
This is a list of pathogenic ClinVar variants found in the CYP2A7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-40875698-G-A | not specified | Uncertain significance (Feb 21, 2024) | ||
19-40875706-A-C | not specified | Uncertain significance (Jan 23, 2024) | ||
19-40875707-A-G | not specified | Uncertain significance (Jan 10, 2022) | ||
19-40875712-A-C | not specified | Uncertain significance (Nov 21, 2023) | ||
19-40875713-T-C | not specified | Uncertain significance (Jan 19, 2022) | ||
19-40875742-A-C | Benign (Dec 31, 2019) | |||
19-40875758-A-G | not specified | Uncertain significance (Aug 22, 2022) | ||
19-40875762-G-C | not specified | Uncertain significance (Jan 30, 2025) | ||
19-40875812-C-T | Likely benign (Dec 01, 2022) | |||
19-40875848-G-T | not specified | Uncertain significance (Oct 09, 2024) | ||
19-40875857-C-T | not specified | Uncertain significance (Jan 18, 2023) | ||
19-40875858-G-C | not specified | Uncertain significance (Jul 14, 2024) | ||
19-40875866-T-A | Benign (Dec 31, 2019) | |||
19-40876559-T-C | not specified | Uncertain significance (Aug 20, 2024) | ||
19-40876573-G-C | not specified | Likely benign (Jun 18, 2021) | ||
19-40876578-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
19-40876638-C-T | Likely benign (Jul 01, 2023) | |||
19-40876639-G-A | Benign (Aug 22, 2018) | |||
19-40877194-G-A | not specified | Uncertain significance (Apr 08, 2024) | ||
19-40877236-C-T | Benign (Jun 15, 2018) | |||
19-40877255-T-A | not specified | Uncertain significance (Apr 24, 2024) | ||
19-40877266-A-G | not specified | Uncertain significance (Nov 15, 2023) | ||
19-40877280-G-T | not specified | Uncertain significance (Apr 04, 2024) | ||
19-40877311-G-C | not specified | Uncertain significance (Dec 09, 2024) | ||
19-40877323-A-C | not specified | Uncertain significance (Aug 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CYP2A7 | protein_coding | protein_coding | ENST00000301146 | 9 | 7314 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.78e-15 | 0.00596 | 125570 | 2 | 176 | 125748 | 0.000708 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.70 | 381 | 298 | 1.28 | 0.0000171 | 3238 |
Missense in Polyphen | 125 | 106.81 | 1.1703 | 1173 | ||
Synonymous | -2.43 | 153 | 119 | 1.28 | 0.00000724 | 929 |
Loss of Function | -0.414 | 21 | 19.1 | 1.10 | 9.34e-7 | 217 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00264 | 0.00264 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000326 | 0.000326 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000392 | 0.000369 |
Middle Eastern | 0.000326 | 0.000326 |
South Asian | 0.00161 | 0.00160 |
Other | 0.000489 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.;
- Pathway
- Vitamin A Deficiency;Retinol Metabolism;Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;Xenobiotics;Tyrosine metabolism;Fatty acids;Androgen and estrogen biosynthesis and metabolism;Cytochrome P450 - arranged by substrate type;Leukotriene metabolism;Biological oxidations;Metabolism;Linoleate metabolism;C21-steroid hormone biosynthesis and metabolism;Xenobiotics metabolism;Tryptophan degradation;CYP2E1 reactions;Arachidonic acid metabolism
(Consensus)
Intolerance Scores
- loftool
- 0.959
- rvis_EVS
- 3.43
- rvis_percentile_EVS
- 99.46
Haploinsufficiency Scores
- pHI
- 0.0572
- hipred
- N
- hipred_score
- 0.112
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.989
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cyp2a5
- Phenotype
- homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- organic acid metabolic process;xenobiotic metabolic process;coumarin metabolic process;epoxygenase P450 pathway;exogenous drug catabolic process;oxidation-reduction process
- Cellular component
- cytoplasm;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle
- Molecular function
- iron ion binding;arachidonic acid epoxygenase activity;steroid hydroxylase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;oxygen binding;heme binding;aromatase activity